Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
A6NFH5
UPID:
FBP12_HUMAN
Alternative names:
-
Alternative UPACC:
A6NFH5; B7SUN0
Background:
Fatty acid-binding protein 12 (FABP12) is implicated in the intricate process of lipid transport within cells. Its role, although not fully delineated, suggests a pivotal function in the cellular lipid homeostasis and metabolism.
Therapeutic significance:
Understanding the role of Fatty acid-binding protein 12 could open doors to potential therapeutic strategies. Its involvement in lipid transport hints at a significant impact on metabolic disorders, offering a promising avenue for research and drug development.